LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 1235 | 2762 | 4583 | 0.6026 | 0.5300 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 1235 | 2413 | 4474 | 0.5393 | 0.4340 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 1235 | 2678 | 4578 | 0.5849 | 0.5057 |
MDA-MB-231 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 1235 | 3432 | 4929 | 0.6963 | 0.6682 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 1235 | 860 | 4355 | 0.1974 | -0.1809 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 1235 | 1171 | 4277 | 0.2738 | -0.0297 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 1235 | 905 | 4583 | 0.1975 | -0.1520 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 1235 | 904 | 4474 | 0.2020 | -0.1551 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 1235 | 933 | 4578 | 0.2038 | -0.1383 |
MDA-MB-231 | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 1235 | 1172 | 4929 | 0.2378 | -0.0263 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 1235 | 767 | 4355 | 0.1761 | -0.2309 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 1235 | 1165 | 4277 | 0.2724 | -0.0325 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 1235 | 762 | 4583 | 0.1663 | -0.2257 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 1235 | 781 | 4474 | 0.1745 | -0.2191 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 1235 | 914 | 4578 | 0.1996 | -0.1476 |
MDA-MB-231 | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 1235 | 881 | 4929 | 0.1787 | -0.1560 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP6 | 1 | G13 | 72 | hr | 1235 | 457 | 4355 | 0.1049 | -0.4216 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP6 | 2 | G13 | 72 | hr | 1235 | 738 | 4277 | 0.1725 | -0.2502 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP6 | 3 | G13 | 72 | hr | 1235 | 584 | 4583 | 0.1274 | -0.3273 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 1 | G13 | 72 | hr | 1235 | 560 | 4474 | 0.1252 | -0.3472 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 2 | G13 | 72 | hr | 1235 | 619 | 4578 | 0.1352 | -0.3065 |
MDA-MB-231 | Withaferin A | 10 | uM | LJP5 | 3 | G13 | 72 | hr | 1235 | 634 | 4929 | 0.1286 | -0.2843 |
MDA-MB-231 | uM | LJP6 | 1 | A03 | 72 | hr | 1235 | 3913 | 4355 | 0.8983 | 0.8854 | ||
MDA-MB-231 | uM | LJP6 | 1 | A04 | 72 | hr | 1235 | 4298 | 4355 | 0.9867 | 0.9853 | ||
MDA-MB-231 | uM | LJP6 | 1 | A05 | 72 | hr | 1235 | 4351 | 4355 | 0.9989 | 0.9988 |